Tavolixizumab, also known as MEDI 0562 or Tavolimab, is a human monoclonal antibody that targets TNFRSF4 (TNF receptor superfamily member 4). This antibody is specifically designed for research applications in cancer immunology, focusing on the modulation of immune responses in oncological studies. Tavolixizumab binds selectively to TNFRSF4, a receptor implicated in the co-stimulation of T cells, playing a crucial role in immune regulation and potential anti-tumor activity. This product is ideal for researchers studying the mechanisms of immune activation and its effects on cancer progression.
Tavolixizumab, also known as MEDI 0562 or Tavolimab, is a human monoclonal antibody that targets TNFRSF4 (TNF receptor superfamily member 4). This antibody is specifically designed for research applications in cancer immunology, focusing on the modulation of immune responses in oncological studies. Tavolixizumab binds selectively to TNFRSF4, a receptor implicated in the co-stimulation of T cells, playing a crucial role in immune regulation and potential anti-tumor activity. This product is ideal for researchers studying the mechanisms of immune activation and its effects on cancer progression.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
